)
Visual
test
INVO Fertility
INVO Fertility (IVF) investor relations material
INVO Fertility Registration Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration Filing summary2 Feb, 2026
Company overview and business model
Operates as a healthcare services and technology company focused on expanding access to assisted reproductive technology (ART) through fertility clinics and proprietary INVOcell® device for intravaginal culture (IVC) procedures.
Strategy includes building, acquiring, and operating fertility clinics, with a shift from device sales to clinic-based services for higher revenue per cycle.
Owns two INVO Centers and one IVF clinic in the U.S., with plans to open additional wholly owned centers in underserved markets.
INVOcell device enables in vivo fertilization, offering a more affordable and intimate alternative to traditional IVF, with comparable success rates.
Recent divestiture of NAYA Therapeutics refocused the business exclusively on fertility services.
Financial performance and metrics
Acquisition of Wisconsin Fertility Institute in August 2023 more than tripled annual revenue and added significant positive cash flow.
Gross proceeds from the exercise of existing warrants in January 2026 totaled approximately $7.5 million before expenses.
May receive up to $15,053,255 in gross proceeds upon full exercise of the Inducement Warrant.
Use of proceeds and capital allocation
Proceeds from warrant exercises intended for acquisitions of additional fertility clinics, capital expenditures, working capital, and general and administrative expenses.
Management has broad discretion over use of proceeds, which may not necessarily improve operating results.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- BETS
Q4 2025 revenue dipped 1% and EBIT fell 24%, but full-year revenue rose 8%. - ALMA
Revenue up 4.6% to €327.1M, digital share 85.9%, profit and cash flow improved. - TMCV
Q2 FY26 delivered double-digit margin growth, record cash flow, and strong market momentum. - DANSKE
Record profit, strong credit quality, and 100% payout; 2026 outlook remains positive. - GREENPLY
Q3 FY26 delivered strong revenue growth but lower profit, with major MDF expansion announced. - KRO
Q1 2025 net income surged to $18.1M on higher TiO2 sales, improved margins, and LPC integration. - WALL
Profit after tax more than tripled to SEK 2,564 million, with net asset value per share up 8%. - TMCVQ3 FY26 delivered 17% revenue growth, 12.7% EBITDA margin, and strong cash flow.
- SHL
Imaging and therapy growth drove 3.8% Q1 revenue; 2026 outlook and EPS guidance confirmed. - SAAB
Record order backlog and double-digit growth across all segments fueled strong 2025 results.
Next INVO Fertility earnings date
Q4 202516 Apr, 2026
INVO Fertility
Next INVO Fertility earnings date
Q4 202516 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
INVO Bioscience Inc develops and markets medical technologies for the treatment of infertility. The company offers devices and solutions designed to enable in vivo fertilization as an alternative to traditional in vitro fertilization procedures. INVO Bioscience operates within the healthcare and medical technology sectors. The company is headquartered in Sarasota, Florida, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage